Caris Life Sciences, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Caris Life Sciences, Inc. now
Current reporting with the operating signal separated from the noise.
Caris Life Sciences, Inc. $CAI Shares Acquired by Sei Investments Co.
Investors are testing whether Caris Life Sciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lazard Asset Management LLC Raises Stock Holdings in Caris Life Sciences, Inc. $CAI
Investors are testing whether Caris Life Sciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Caris Life Sciences, Inc. $CAI Stake Lessened by Rock Springs Capital Management LP
The development tests whether Caris Life Sciences, Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Latest CAI filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Caris Life Sciences, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →